
Lupin Limited has informed the Exchange regarding a press release dated March 07, 2025, titled "Lupin Launches Rivaroxaban Tablets USP, 2.5 mg in the United States".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated March 07, 2025, titled "Lupin Launches Rivaroxaban Tablets USP, 2.5 mg in the United States".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin